Test 4 Study Guide Flashcards
Surfactant replacement therapy is for
_____
Respiratory distress
____ is the most common cause of death of surfactant deficiency
Pediatric RDS
Surfactant reduces _____
Surface tension
Alveoli is formed at ____ weeks
32 weeks
_____ prevents alveolar collapse during exhalation
Surface tension
The stage when type II cells mature
22 weeks
Any baby over ____ weeks can be saved.
22 weeks
Steroid given 24-48 hours before delivery to speed up lung development
Dexamethasone
_____ is prevention treatment
Prophylactic
Two main strategies for the prevention of neonatal ARDS in cases of preterm delivery
- Antenatal administration of hormones
- Prophylactic treatment with surfactant soon after birth
Surfactant accelerates ______ pneumocytes
Type II pneumocytes
( increase exchange and improve lung mechanics. Maximal lung volume, compliance and gas exchange.)
Administration of surfactant is based on ____ and ____
gestational age and birth weight
Outcomes of surfactant
Increased compliance
Decreased WOB
Decreased shunting
Decreased atelectasis
Improvement of shunt ratio
Can’t survive without ___ protein
B protein
Rescue surfactant is only for ____
ARDS
Surfactant is given in the ____ position
Supine
Complications of surfactant
Plugging of the ETT
Bradycardia
The temperature for surfactant should be ____
Room temperature
You need _____ for surfactant delivery
Multiaccess
_____ stage continues after birth
Alveolar postnatal stage
Layer where lung tissue is formed
Endodermic layer
Stage that occurs during gestational weeks of 7-17
Pseudoglandular stage
Stage in which the alveolar sac develops
Canalicular stage
Stage develops between 17-26 weeks
Canalicular stage
Formulation of type I and type II pneumocytes
20-22 weeks gestation (Canalicular stage)